- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/107 - Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Patent holdings for IPC class C07D 491/107
Total number of patents in this class: 2381
10-year publication summary
|
128
|
136
|
178
|
186
|
198
|
216
|
219
|
225
|
215
|
134
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10262 |
63 |
| Hoffmann-La Roche Inc. | 3793 |
51 |
| VALO Health, Inc. | 193 |
44 |
| Bristol-myers Squibb Company | 4742 |
41 |
| F. Hoffmann-La Roche AG | 7837 |
37 |
| Merck Sharp & Dohme LLC | 3734 |
35 |
| Takeda Pharmaceutical Company Limited | 2712 |
34 |
| Gilead Sciences, Inc. | 2222 |
34 |
| Merck Patent GmbH | 5728 |
31 |
| Vertex Pharmaceuticals Incorporated | 1582 |
28 |
| Amgen Inc. | 4427 |
25 |
| Kala bio, Inc. | 42 |
24 |
| Shionogi & Co., Ltd. | 880 |
21 |
| Boehringer Ingelheim International GmbH | 4493 |
19 |
| Genentech, Inc. | 4104 |
18 |
| Pfizer Inc. | 3386 |
17 |
| Bayer AG | 3501 |
17 |
| Bayer Pharma AG | 1014 |
17 |
| Nurix Therapeutics, Inc. | 115 |
17 |
| AstraZeneca AB | 2814 |
16 |
| Other owners | 1792 |